In the last trading session, 1.38 million ORIC Pharmaceuticals Inc (NASDAQ:ORIC) shares changed hands as the company’s beta touched 1.47. With the company’s per share price at $9.32 changed hands at $0.16 or 1.75% during last session, the market valuation stood at $662.54M. ORIC’s last price was a discount, traded about -57.4% off its 52-week high of $14.67. The share price had its 52-week low at $3.90, which suggests the last value was 58.15% up since then.
Analysts gave the ORIC Pharmaceuticals Inc (ORIC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.08. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ORIC as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. ORIC Pharmaceuticals Inc’s EPS for the current quarter is expected to be -0.45.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) trade information
Instantly ORIC was in green as seen at the end of in last trading. With action 14.08%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 15.49%, with the 5-day performance at 14.08% in the green. However, in the 30-day time frame, ORIC Pharmaceuticals Inc (NASDAQ:ORIC) is 98.30% up.
The consensus price target for the stock as assigned by Wall Street analysts is 12, meaning bulls need an upside of 22.33% from its current market value. According to analyst projections, ORIC’s forecast low is 12 with 12 as the target high. To hit the forecast high, the stock’s price needs a -28.76% plunge from its current level, while the stock would need to soar -28.76% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -15.32%. The 2025 estimates are for ORIC Pharmaceuticals Inc earnings to increase by 1.57%, but the outlook for the next 5-year period is at 5.83% per year.
ORIC Dividends
ORIC Pharmaceuticals Inc is expected to release its next quarterly earnings report in July.
FMR LLC holds the second largest percentage of outstanding shares, with 6.9943% or 4.92 million shares worth $34.79 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were ACAP Strategic Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 1.98 shares estimated at $18.47 million under it, the former controlled 2.79% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.65% of the shares, roughly 1.88 shares worth around $17.55 million.
